John Flannery has been named president and chief executive officer of GE Healthcare, effective immediately. Flannery replaces John Dineen, who will leave the company.
GE Healthcare’s U.S. headquarters is in Wauwatosa.
Flannery, 53, has worked at GE for 27 years, most recently as senior vice president of business development for GE, where he developed business following the acquisition of Alstom’s energy and transmission businesses, the spinoff of retail finance and the sale of GE Appliances. He previously served as president and CEO of GE India and a senior leader at GE Capital.
“With 27 years of experience across GE corporate, GGO and Capital, John has a track record of growing businesses with a special emphasis on global expansion,” said Jeff Immelt, CEO of GE. “He has a deep understanding of GE’s industrial businesses and strategy. He’s the right person to lead the next chapter at GE Healthcare.”
Dineen, 51, spent 28 years at GE, the past seven of which were spent leading GE Healthcare. Dineen also held senior positions in GE Industrial Systems, Plastics, Transportation and Healthcare. He is pursuing a leadership role outside the organization.
“John has been a highly respected and influential leader in our company for many years,” Immelt said. “John successfully led GE Healthcare during a period of growth, portfolio diversification and market volatility. Thanks to his leadership, the business today is a global leader with a strong brand and great technology.”
GE Healthcare manufactures medical imaging devices, life sciences tools, medical diagnostic agents and health care IT and software tools. It has $20 billion in annual revenue.
“Healthcare remains a core part of the GE portfolio,” Immelt said. “We are a market leader with deep innovation from our Global Research Center. Healthcare is an important driver for GE’s strategy in growth markets and the Industrial Internet. GE is poised to benefit as Healthcare spending continues to grow around the world.”
